Larimar Therapeutics, Inc. - 10-Q Filing
Larimar Therapeutics reports Q3 financial results including research and development, general and administrative, and technical operations expenses.
Tickers: $LRMR
Larimar Therapeutics reports Q3 financial results including research and development, general and administrative, and technical operations expenses.
Tickers: $LRMR